HOOK: hookipapharma.com Kompaniya qiymatining sof foydaga nisbati
HOOKIPA Pharma Inc. (HOOK) daromadlari strategik hamkorlarning to'lovlariga va Vaxwave terapiyasining tijoratlashtirilishiga asoslangan. Shu bilan birga, kompaniya zararli emissiyalarni minimallashtirish uchun o'z laboratoriyalarida energiya tejamkor yechimlarni joriy etmoqda. Hozirgi vaqtda R&D markazi onkologiya uchun istiqbolli immun dorilarini sinovdan o'tkazmoqda. Joriy PE koeffitsiyenti -0.10 ni tashkil etadi, bu esa kompaniyaning narxlar grafigida batafsil ko'rsatilgan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_HOOK_-_HOOKIPA-Pharma-Inc._-_PE-Multiple "HOOK: HOOKIPA Biznesning o‘zini qoplash muddati 04.07.2022 - 16.08.2025 | 👁️GURU.Markets👁️")
HOOKIPA Pharma, Inc. (HOOK) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HOOKIPA Pharma Inc.|HOOK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati HOOKIPA|HOOK - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati HOOKIPA Pharma Inc.|HOOK - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz HOOKIPA Pharma|Oraliq qoplash koeffitsiyenti hookipapharma.com
- foyda va bozor multiplikatorlari tafsilotlari:
HOOK - Kompaniyaning sof foydasi|Kutilayotgan sof foyda HOOKIPA Pharma Inc.|HOOK - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati HOOKIPA|HOOK - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori HOOKIPA Pharma Inc.|HOOK - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda HOOKIPA Pharma|HOOK - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi hookipapharma.com|HOOK - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi HOOKIPA Pharma Inc.
Kompaniyaning har tomonlama tahlili:hookipapharma.com HOOK
Himoya aktivlari ularning fundamental ko'rsatkichlarining barqarorligiga asoslanib tanlanadi. HOOKIPA Pharma Inc. (HOOK) strategik ittifoqlar orqali kapital xarajatlarini optimallashtiruvchi kompetent boshqaruv orqali ushbu standartni namoyish etadi. Kompaniyaning forward P/E ko'rsatkichida aks etgan bozor kapitalizatsiyasining sof foydaga nisbati bir birlik foyda narxini o'lchaydi. Ushbu ko'rsatkich kelajakdagi o'sish uchun to'lovning haddan tashqari ko'pligi darajasini belgilaydi. Grafikning narx harakati biotexnologik ishlanmalarning samaradorligi bo'yicha bozor kutganlarini baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TRML (Tourmaline)|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Kapitalizatsiyaning foydaga nisbati Upstream Bio, Inc. UPB|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|P/E multiplikatori Immunome Bio (IMNM)|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|Biznesning o‘zini qoplash muddati kalvista.com (KALV)|SEPN - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PVLA|SVRA: P/E multiplikatori|Rigel Corp (RIGL) - P/E multiplikatori|Narx-foyda koeffitsiyenti ANAB|ATXS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati enGene (ENGN)|RAPT: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori JBIO (Aerovate Therapeutics)|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics - P/E multiplikatori|TLSA - P/E multiplikatori|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Ventyx Biosciences Inc. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Theratechnologies Inc|Narx-foyda koeffitsiyenti Avalo Therapeutics Inc (AVTX)|P/E multiplikatori ELDN|P/E multiplikatori agenusbio.com (AGEN)|Climb Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ZURA|aTyr - P/E multiplikatori|Biznesning o‘zini qoplash muddati Adagene ADAG|ikenaoncology.com (IMA) - Narxning foydaga nisbati|Narx-foyda multiplikatori STTK|EQ (Equillium Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Connect Pharma (CNTB)|Narx-foyda koeffitsiyenti IMUX (Immunic, Inc.)|Biznesning o‘zini qoplash muddati atarabio.com|P/E multiplikatori IFRX (InflaRx)|Kompaniya qiymatining sof foydaga nisbati XFOR|ACET - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Celularity Inc.|INmune Bio Corp (INMB) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Barinthus Biotherapeutics Corp (BRNS)|Narxning foydaga nisbati Kezar Life Sciences|P/E multiplikatori sabbiotherapeutics.com|Narxning foydaga nisbati Akari Therapeutics Plc (AKTX)|ENLV: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|Kompaniya qiymatining sof foydaga nisbati GOVX|Edesa Biotech, Inc. - P/E multiplikatori|IBIO - P/E multiplikatori|carismatx.com (CARM) - Narxning foydaga nisbati|XTL Biopharmaceuticals Ltd - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Bolt Biotherapeutics Inc.|Narx-foyda koeffitsiyenti HCW Biologics Inc (HCWB)|P/E multiplikatori APVO|P/E multiplikatori AIM ImmunoTech, Inc. (AIM)|Aditxt, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati GRI|XORTX - P/E multiplikatori|Biznesning o‘zini qoplash muddati Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti indaptusrx.com|Narxning foydaga nisbati Scinai Immunotherapeutics Ltd.|Narx-foyda koeffitsiyenti CalciMedica Corp (CALI)|Narx-foyda koeffitsiyenti AFMD (Affimed)|P/E multiplikatori allakos.com (ALLK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|THRD: P/E multiplikatori
